keyword
Keywords Radiation induced secondary ma...

Radiation induced secondary malignancy

https://read.qxmd.com/read/38558762/risk-of-secondary-malignancies-after-pelvic-radiation-a-population-based-analysis
#1
JOURNAL ARTICLE
Connor McPartland, Andrew Salib, Joshua Banks, James R Mark, Costas D Lallas, Edouard J Trabulsi, Leonard G Gomella, Hanan Goldberg, Benjamin Leiby, Robert Den, Thenappan Chandrasekar
BACKGROUND AND OBJECTIVE: Radiation therapy has increasingly been used in the management of pelvic malignancies. However, the use of radiation continues to pose a risk of a secondary malignancy to its recipients. This study investigates the risk of secondary malignancy development following radiation for primary pelvic malignancies. METHODS: A retrospective cohort review of the Surveillance, Epidemiology, and End Results database from 1975 to 2016 was performed...
May 2024: European urology open science
https://read.qxmd.com/read/38510819/extrahepatic-90-y-complication-gastric-ulcer-secondary-to-90-y-therapy-for-liver-metastasis-despite-negative-preprocedural-imaging
#2
Connor Shea, Hannah Lamberg, Sevcan Turk, Mamadou Sanogo, Danielle Turgeon, Broko Nojkov, Kirk Frey, David Raffel
Transarterial radioembolization using yttrium-90 (90 Y) therapy has become a standard modality of treatment for primary and metastatic liver malignancies due to its high efficacy rate and relatively low risk of adverse effects compared to other forms of locoregional and systemic therapies. Non-target distribution of radio embolic beads and adjacent structure radiation are the two most common adverse effects. However, these are rarely encountered due to thorough imaging and mapping studies prior to 90 Y therapy...
April 2024: Nuclear Medicine and Molecular Imaging
https://read.qxmd.com/read/38450016/utilizing-a-second-flap-to-address-the-effect-of-postradiotherapy-soft-tissue-fibrosis-in-head-and-neck-malignancy
#3
JOURNAL ARTICLE
Gautam Biswas, Jovin George Mathew, Amrita Kaur, Karnav Bharat Panchal
Background  Late effects of adjuvant radiation therapy (RT) on soft tissues can lead to hair loss, pigmentary changes, loss of tissue volume, and fibrosis, which appear months to years after the treatment. These changes are often progressive and are because of tissue hypoxia due to radiation-induced capillary endothelial damage. Tissue hypoxia may be compounded by subclinical infection following minor trauma, exposed hardware, or associated osteoradionecrosis. The combined effect of these factors causes significant deformities in soft tissue, affecting both function and appearance...
February 2024: Indian Journal of Plastic Surgery: Official Publication of the Association of Plastic Surgeons of India
https://read.qxmd.com/read/38435840/treatment-of-abdominal-desmoplastic-small-round-cell-tumor-induces-acute-myeloid-leukemia-m5-a-case-report-and-literature-review
#4
Lan Liu, Meizuo Zhong, Xuan Zhou, Fanhua Kang, Yong Long, Junfeng Li
Desmoplastic small round cell tumor (DSRCT) is a rare and highly aggressive malignancy. Most patients are diagnosed at a late stage with poor prognosis. The treatment usually includes combined intensive chemotherapy, cytoreductive surgery, radiotherapy, and targeted therapy. Due to the low incidence rate and dismal survival, there is currently a lack of case reports on DSRCT with concurrent leukemia. We report a case of a young patient who achieved disease stabilization for 14 months after receiving 6 cycles of chemotherapy and whole abdominal radiation therapy (WART), followed by consolidation treatment with anlotinib...
2024: OncoTargets and Therapy
https://read.qxmd.com/read/38371218/can-the-malnutrition-universal-screening-tool-must-predict-healing-complications-following-microvascular-reconstruction-of-the-head-and-neck
#5
JOURNAL ARTICLE
Camilo Mosquera, Marina Morante Silva, Ashleigh M Weyh, Michael A Malik, Rui Fernandes
STUDY DESIGN: Retrospective cohort study. OBJECTIVE: Malnutrition has been found to have negative effects on the immune system and inflammatory responses, impairing the wound healing process. Free flap failure is a serious complication in patients undergoing microvascular reconstruction, as it increases patient morbidity, length of stay in the hospital, patient, and hospital costs, as well as causes the need for further surgical interventions1 . Malnutrition is estimated to be present in 35-50% of head and neck cancer patients with higher rates in those experiencing hypo-oropharyngeal disease...
March 2024: Craniomaxillofacial Trauma & Reconstruction
https://read.qxmd.com/read/38358528/risk-of-hematologic-malignant-neoplasms-from-head-ct-radiation-in-children-and-adolescents-presenting-with-minor-head-trauma-a-nationwide-population-based-cohort-study
#6
JOURNAL ARTICLE
Seungjae Lee, Hae Young Kim, Kyung Hee Lee, Jungheum Cho, Choonsik Lee, Kwang Pyo Kim, Jinhee Hwang, Ji Hoon Park
OBJECTIVES: The carcinogenic risks of CT radiation in children and adolescents remain debated. We aimed to assess the carcinogenic risk of CTs performed in children and adolescents with minor head trauma. METHODS: In this nationwide population-based cohort study, we included 2,411,715 patients of age 0-19 with minor head trauma from 2009 to 2017. We excluded patients with elevated cancer risks or substantial past medical radiation exposure. Patients were categorized into CT-exposed or CT-unexposed group according to claim codes for head CT...
February 15, 2024: European Radiology
https://read.qxmd.com/read/38256084/hypoxia-modulates-radiosensitivity-and-response-to-different-radiation-qualities-in-a549-non-small-cell-lung-cancer-nsclc-cells
#7
JOURNAL ARTICLE
Hasan Nisar, Frederik M Labonté, Marie Denise Roggan, Claudia Schmitz, François Chevalier, Bikash Konda, Sebastian Diegeler, Christa Baumstark-Khan, Christine E Hellweg
Hypoxia-induced radioresistance reduces the efficacy of radiotherapy for solid malignancies, including non-small cell lung cancer (NSCLC). Cellular hypoxia can confer radioresistance through cellular and tumor micro-environment adaptations. Until recently, studies evaluating radioresistance secondary to hypoxia were designed to maintain cellular hypoxia only before and during irradiation, while any handling of post-irradiated cells was carried out in standard oxic conditions due to the unavailability of hypoxia workstations...
January 13, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38140719/estimation-of-the-added-cancer-risk-derived-from-evar-and-cta-follow-up
#8
JOURNAL ARTICLE
Bharti Singh, Martin Andersson, Andreas Edsfeldt, Björn Sonesson, Mikael Gunnarsson, Nuno V Dias
OBJECTIVE: The aim of this study was to assess the risk of radiation-induced cancer development in patients that have undergone an infrarenal EVAR, stratifying the relative contributions of the procedure and the preoperative and postoperative CTAs. METHODS AND MATERIALS: The organ-specific absorbed radiation doses from CTA and the EVAR procedure were estimated from the radiation exposures of 95 and 45 male patients, respectively. Lifetime attributable risk (LAR) cancer predictions were calculated for 14 different organs...
December 22, 2023: Journal of Endovascular Therapy
https://read.qxmd.com/read/38108313/third-stereotactic-radiosurgery-for-residual-arteriovenous-malformations-a-retrospective-multicenter-study
#9
JOURNAL ARTICLE
Stylianos Pikis, Georgios Mantziaris, Chloe Dumot, Ahmed Shaaban, Maria Protopapa, Zhiyuan Xu, Ajay Niranjan, Zhishuo Wei, Priyanka Srinivasan, Lilly W Tang, Roman Liscak, Jaromir May, Nuria Martinez Moreno, Roberto Martinez Álvarez, Selcuk Peker, Yavuz Samanci, Ahmed M Nabeel, Wael A Reda, Sameh R Tawadros, Khaled Abdelkarim, Amr M N El-Shehaby, Reem M Emad, Ahmed Hesham Elazzazi, Varun Padmanaban, Francis J Jareczek, James McInerney, Kevin M Cockroft, Dade Lunsford, Jason P Sheehan
BACKGROUND AND OBJECTIVES: There are no studies evaluating the efficacy and safety of more than 2 stereotactic radiosurgery (SRS) procedures for cerebral arteriovenous malformations (AVM). The aim of this study was to provide evidence on the role of third single-session SRS for AVM residual. METHODS: This multicenter, retrospective study included patients managed with a third single-session SRS procedure for an AVM residual. The primary study outcome was defined as AVM nidus obliteration without AVM bleeding or symptomatic radiation-induced changes (RIC)...
December 18, 2023: Neurosurgery
https://read.qxmd.com/read/38104131/induction-of-double-strand-breaks-with-the-non-steroidal-androgen-receptor-ligand-flutamide-in-patients-on-androgen-suppression-a-study-protocol-for-a-randomized-double-blind-prospective-trial
#10
JOURNAL ARTICLE
Emerson Lee, Jonathan Coulter, Alok Mishra, Fernanda Caramella-Pereira, Angelo Demarzo, Michelle Rudek, Chen Hu, Misop Han, Theodore L DeWeese, Srinivasan Yegnasubramanian, Daniel Y Song
BACKGROUND: Prostate cancer remains the most prevalent malignancy and the second-leading cause of cancer-related death in men in the USA. Radiation therapy, typically with androgen suppression, remains a mainstay in the treatment of intermediate- and high-risk, potentially lethal prostate cancers. However, local recurrence and treatment failure remain common. Basic and translational research has determined the potential for using androgen receptor (AR) ligands (e.g., dihydrotestosterone and flutamide) in the context of androgen-deprived prostate cancer to induce AR- and TOP2B-mediated DNA double-strand breaks (DSBs) and thereby synergistically enhance the effect of radiation therapy (RT)...
December 16, 2023: Trials
https://read.qxmd.com/read/38087368/histopathologically-confirmed-radiation-induced-damage-of-the-brain-an-in-depth-analysis-of-radiation-parameters-and-spatio-temporal-occurrence
#11
JOURNAL ARTICLE
Mario R P Kossmann, Felix Ehret, Siyer Roohani, Sebastian F Winter, Pirus Ghadjar, Güliz Acker, Carolin Senger, Simone Schmid, Daniel Zips, David Kaul
BACKGROUND: Radiation-induced damage (RID) after radiotherapy (RT) of primary brain tumors and metastases can be challenging to clinico-radiographically distinguish from tumor progression. RID includes pseudoprogression and radiation necrosis; the latter being irreversible and often associated with severe symptoms. While histopathology constitutes the diagnostic gold standard, biopsy-controlled clinical studies investigating RID remain limited. Whether certain brain areas are potentially more vulnerable to RID remains an area of active investigation...
December 12, 2023: Radiation Oncology
https://read.qxmd.com/read/38067287/treatment-and-outcomes-of-radiation-induced-soft-tissue-sarcomas-of-the-extremities-and-trunk-a-systematic-review-of-the-literature
#12
REVIEW
Maria L Inchaustegui, Kelly Kon-Liao, Kim Ruiz-Arellanos, George Aquilino E Silva, Marcos R Gonzalez, Juan Pretell-Mazzini
INTRODUCTION: Radiation-induced soft tissue sarcomas (RISs) are rare secondary malignancies with a dire prognosis. The literature on the management of these tumors remains scarce due to their low incidence. Our systematic review sought to assess the treatment alternatives and outcomes of patients with RIS. METHODS: A systematic review was conducted following the PRISMA guidelines. Our study was registered in PROSPERO (ID: CRD42023438415). Quality assessment was performed using the STROBE checklist...
November 25, 2023: Cancers
https://read.qxmd.com/read/38060066/focused-ultrasound-combined-with-radiotherapy-for-malignant-brain-tumor-a-preclinical-and-clinical-study
#13
JOURNAL ARTICLE
Ko-Ting Chen, Chiung-Yin Huang, Ping-Ching Pai, Wen-Chi Yang, Chen-Kan Tseng, Hong-Chieh Tsai, Jui-Chin Li, Chi-Cheng Chuang, Peng-Wei Hsu, Cheng-Chi Lee, Cheng-Hong Toh, Hao-Li Liu, Kuo-Chen Wei
INTRODUCTION: Blood-brain barrier (BBB) remains to be the major obstacle to conquer in treating patients with malignant brain tumors. Radiation therapy (RT), despite being the mainstay adjuvant modality regardless of BBB, the effect of radiation induced cell death is hindered by the hypoxic microenvironment. Focused ultrasound (FUS) combined with systemic microbubbles has been shown not only to open BBB but also potentially increased regional perfusion. However, no clinical study has investigated the combination of RT with FUS-BBB opening (RT-FUS)...
December 7, 2023: Journal of Neuro-oncology
https://read.qxmd.com/read/38048750/incidence-of-secondary-cancers-after-neoadjuvant-therapy-for-locally-advanced-rectal-cancer
#14
JOURNAL ARTICLE
Praachi Raje, Swati Sonal, Chloe Boudreau, Hiroko Kunitake, Robert N Goldstone, Liliana G Bordeianou, Christy E Cauley, Todd D Francone, Rocco Ricciardi, Grace C Lee, David L Berger
INTRODUCTION: Whether neoadjuvant chemoradiation for locally advanced rectal cancer (LARC) induces secondary cancers is controversial. This retrospective cohort study describes the incidence of secondary cancers in LARC patients. METHODS: We compared 364 LARC patients who received conventional (50.4 Gy) or short course neoadjuvant radiation (25 Gy x 5 fractions) followed by resection to 142 patients with surgically resected rectal cancer who did not receive radiation at a single institution from 2004 to 2018...
December 3, 2023: Journal of Surgical Research
https://read.qxmd.com/read/37917577/risk-and-prognostics-of-second-primary-cancer-after-prostate-radiation-therapy
#15
JOURNAL ARTICLE
Elisa K Liu, Thomas B Daniels, Jonathan W Lischalk, Cheongeun Oh, Jonathan A Haas, Andrew J Evans, David J Byun
INTRODUCTION: As overall survival in prostate cancer increases due to advances in early detection and management, there is a growing need to understand the long-term morbidity associated with treatment, including secondary tumors. The significance of developing radiation-associated secondary cancers in an elderly population remains unknown. METHODS: Patients diagnosed with prostate cancer between 1975 and 2016 in one of 9 Surveillance, Epidemiology, and End Results registries were included in this study...
November 1, 2023: Urology Practice
https://read.qxmd.com/read/37894389/proton-therapy-for-advanced-juvenile-nasopharyngeal-angiofibroma
#16
JOURNAL ARTICLE
Line Hoeltgen, Thomas Tessonnier, Eva Meixner, Philipp Hoegen, Ji-Young Kim, Maximilian Deng, Katharina Seidensaal, Thomas Held, Klaus Herfarth, Juergen Debus, Semi Harrabi
PURPOSE: To provide the first report on proton radiotherapy (PRT) in the management of advanced nasopharyngeal angiofibroma (JNA) and evaluate potential benefits compared to conformal photon therapy (XRT). METHODS: We retrospectively reviewed 10 consecutive patients undergoing PRT for advanced JNA in a definitive or postoperative setting with a relative biological effectiveness weighted dose of 45 Gy in 25 fractions between 2012 and 2022 at the Heidelberg Ion Beam Therapy Center...
October 17, 2023: Cancers
https://read.qxmd.com/read/37809227/radiation-associated-angiosarcoma-as-a-presentation-of-disease-progression-in-a-patient-on-immunotherapy-for-metastatic-non-small-cell-lung-cancer
#17
Hannah Tan, Beatrice E Torere, Sherry Okun, Benjamin Hinton
Non-small cell lung cancer (NSCLC) is the dominant form of lung cancer, comprising around 85% of cases. Stage 4 NSCLC has a grim prognosis; however, immunotherapy and radiation therapy have become vital treatments for advanced-stage NSCLC, despite the risk of inducing a second primary malignancy. This case report focuses on a 45-year-old female diagnosed with NSCLC and metastasis to the 11th thoracic vertebral body. After various treatments, including radiation, a potential radiation-associated secondary malignancy, epithelial angiosarcoma, was discovered...
September 2023: Curēus
https://read.qxmd.com/read/37760419/morphea-eosinophilic-fasciitis-and-cancer-a-scoping-review
#18
REVIEW
Maxine Joly-Chevrier, Alexa Gélinas, Stephanie Ghazal, Sarah Moussa, Catherine C McCuaig, Maryam Piram, Alexandra Mereniuk, Ivan V Litvinov, Mohammed Osman, Kevin Pehr, Elena Netchiporouk
Morphea is an autoimmune fibrotic skin disease. Eosinophilic fasciitis (EF) is considered to belong to the severe spectrum of morphea. We conducted a scoping review assessing the risk of secondary cancer among morphea/EF patients, paraneoplastic morphea/EF and morphea/EF developing secondary to cancer therapy. The search was conducted using MEDLINE, Embase, Cochrane databases for articles published from inception to September 2022 following the Preferred Reporting Items for Systematic reviews and Meta-Analyses for Scoping Reviews (PRISMA-ScR) guidelines with no language or date restrictions...
September 7, 2023: Cancers
https://read.qxmd.com/read/37747407/secondary-cancers-risk-assessments-following-the-proton-therapy-of-lung-cancer-as-the-functions-of-field-characteristics-and-patient-age
#19
JOURNAL ARTICLE
Sayyed Bijan Jia, Reza Shamsabadi
Introduction: Radiation-induced secondary cancers relevant to proton therapy are still a main concern among cancer survivors. This study aims to determine the effects of age at exposure and treatment field size on radiation-induced secondary tumors following the proton therapy of lung cancer within out of field organs through Monte Carlo (MC) simulation approach. Material and Methods: A full MC model of ICRP-110 male phantom was simulated to calculate the absorbed dose corresponding to secondary radiations within distant organs from the tumor volume...
September 25, 2023: International Journal of Radiation Biology
https://read.qxmd.com/read/37739316/favourable-outcomes-with-an-initial-active-surveillance-strategy-for-asymptomatic-radiation-induced-meningiomas-in-long-term-survivors-of-paediatric-and-young-adult-malignancies
#20
JOURNAL ARTICLE
Mary Xu, Arian Lasocki, Mathias Bressel, Natalie Goroncy, Greg Wheeler, Mary Dwyer, Kirsty Wiltshire, John F Seymour, Neda Haghighi, Kylie Mason, Damien Tange, Belinda A Campbell
PURPOSE: Radiation-induced meningiomas (RIM) are the most common secondary neoplasm post-cranial radiotherapy, yet optimal surveillance and treatment strategies remain contentious. Herein, we report the clinical outcomes and radiological growth rate of RIM, diagnosed in a cohort of survivors undergoing MRI screening, with the objective of informing clinical guidelines and practice. MATERIALS AND METHODS: Long-term survivors of paediatric or young-adult malignancies, diagnosed with RIM between 1990-2015, were identified...
September 20, 2023: Radiotherapy and Oncology
keyword
keyword
23847
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.